CD34 and non-small cell lung carcinoma: We found that the growth of the NSCLC tumor xenografts was inhibited by PD98095 (Fig. 3c), while immunohistochemical staining showed that HIF-1a and CD34 expression was significantly decreased (Fig. 4a-d).